{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-028567","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.768596+00:00","generated_at":"2026-05-17T07:38:03.783410+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NRx Pharmaceuticals raises $8.8M, announces HOPE Therapeutics launch and Rockefeller advisory role","bullets":["Raised $8.8M gross from experienced biotech investors via common stock offering; no warrants or variable rate features.","HOPE Therapeutics subsidiary to launch in September 2025 with flagship location in Palm Beach, FL.","Clinics will combine ketamine, transcranial magnetic stimulation, hyperbaric oxygen for suicidal depression, PTSD, TBI.","Matthew Rockefeller joins HOPE Therapeutics Advisory Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-028567","json":"https://secwatch.observer/filing/0001437749-25-028567.json","markdown":"https://secwatch.observer/filing/0001437749-25-028567.md","text":"https://secwatch.observer/filing/0001437749-25-028567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/0001437749-25-028567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/nrxp20250908_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:38:03.783410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}